Nav: Home

Clodagh O'Shea named HHMI Faculty Scholar for work in designing synthetic viruses

October 12, 2016

LA JOLLA--Clodagh O'Shea, an associate professor in the Salk Institute's Molecular and Cell Biology Laboratory, is among the first recipients of a grant from the Faculty Scholars Program, a new partnership of Howard Hughes Medical Institute (HHMI), the Bill & Melinda Gates Foundation and the Simons Foundation for early career researchers whose work shows the potential for groundbreaking contributions in their fields. O'Shea is one of 84 Faculty Scholars who will receive $100,000-$400,000 per year over five years to support their pursuit of innovative research.

O'Shea is at the forefront of cutting-edge technologies to design synthetic viruses and other genetic devices that are controlled and able to selectively target cancer cells. Each time a virus infects a cancer cell and multiplies, the virus kills the cell by bursting it open to release thousands of viral progenies, which go on to target other cancer cells. Synthetic viruses designed to lock onto and rupture cancer cells while leaving normal cells intact could result in a novel cancer therapy with virtually no side effects.

"Clodagh's innovative and cutting-edge research has the potential to unlock promising new ways of precisely and effectively targeting cancers and indeed opens new avenues for treating other diseases as well," said Salk President Elizabeth Blackburn. "We are extremely pleased that her work is being recognized with an inaugural grant from this important program."

To successfully redesign and program synthetic viral therapies, O'Shea has developed new technologies that enable viral gene delivery devices, cancer therapies and vaccines to be assembled using libraries of modular DNA parts, akin to using Lego pieces to build a sculpture or robot. O'Shea proposes to further develop these genetic machines as diagnostic 'drones' that identify the earliest traces of cancer; synthetic viruses that act like guided missiles to destroy tumor cells while preventing therapeutic resistance; and viruses that home in on damaged tissues to promote wound healing and stave off infection.

"I am very honored to receive a HHMI faculty scholar award, which we will use to identify critical 3D genomic interactions that are subverted in both viral infection and cancer and the rational design of powerful synthetic viral therapies for the treatment of patients suffering from cancer," says O'Shea, who is the holder of the William Scandling Developmental Chair.

Another aspect of O'Shea's research is to unravel the structural code that determines the functions of DNA in the cell nucleus and if it can be accessed and used. A cell's genomic material is not a simple helix: DNA is coiled around proteins to form complex three-dimensional packages called chromatin to fit into the small space of a cell nucleus. Charting and determining the structure of chromatin at multiple scales is a vital step in understanding how viruses access genetic material to replicate and kill cells. To this end, her lab is developing new techniques to visualize how genomic material is structured in time and space. These studies have the potential to reveal the structural code that determines if a gene is 'on' or 'off' state in health and disease.

The program's support enables O'Shea, who has made dramatic progress in building selectively replicating cancer-killing viruses as well as visualizing chromatin, to further refine her genetic machines and designs to be able to, for example, keep up with a tumor's constantly molecular variations (heterogeneity), engage a protective immune response and target specific mutations related to hard-to-treat cancers (e.g., p53 mutations).

"We are very excited to welcome these accomplished scientists into the HHMI community," said HHMI President Erin O'Shea. "We're equally gratified to work alongside our philanthropic partners to help these early-career scientists move science forward by pursuing their bold ideas."
The Faculty Scholars competition is open to basic researchers and physician scientists at more than 220 eligible institutions who bring innovative approaches to the study of biological problems. Early-career researchers with more than 4, but no more than 10, years of experience as faculty members were eligible to apply for this competition. Read more at HHMI:

About the Salk Institute for Biological Studies:

Every cure has a starting point. The Salk Institute embodies Jonas Salk's mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer's, aging or diabetes, Salk is where cures begin.

Salk Institute

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab